The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
The product is bioequivalent and therapeutically equivalent to Fresenius Kabi’s reference drug (NDA 212832)
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The endorsement follows overwhelming support for the share swap preceding the merger,
Subscribe To Our Newsletter & Stay Updated
